Michael Platten 个人学术档案

引用次数

	总计	2019 年至今
引用	38388	25950
h 指数	89	72
i10 指数	258	232

6000

3000

1500

4500

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024108 105 166 164 240 234 286 309 377 442 612 749 941 1341 1667 1913 2349 2711 3543 4731 5477 5404 3997

开放获取的出版物数量

查看全部

144 篇文章

20 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Wolfgang WickUniversity of Heidelberg在 med.uni-heidelberg.de 的电子邮件经过验证
Andreas von DeimlingNeuropathology, University Heidelberg / CCU Neuropathology, German Cancer Center在 med.uni-heidelberg.de 的电子邮件经过验证
Felix SahmDept. of Neuropathology Heidelberg在 dkfz.de 的电子邮件经过验证
Christiane A. OpitzDivision Head "Metabolic Crosstalk in Cancer", German Cancer Research Center (DKFZ)在 dkfz.de 的电子邮件经过验证
Lukas Bunse, MD, PhDDKFZ Heidelberg Germany, University Heidelberg在 dkfz.de 的电子邮件经过验证
Guido Reifenberger在 med.uni-duesseldorf.de 的电子邮件经过验证
Tobias Kessler在 dkfz-heidelberg.de 的电子邮件经过验证
Tobias LanzStanford University在 stanford.edu 的电子邮件经过验证
Ulrike LitzenburgerPostdoc, Howard Y Chang laboratory, School of Medicine, Stanford在 stanford.edu 的电子邮件经过验证
Martina OttInstructor, The University of Texas MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
Ghazaleh TabatabaiChair, Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen在 med.uni-tuebingen.de 的电子邮件经过验证
Stefan M. PfisterProfessor of Pediatrics, Hopp-Children´s Cancer Center Heidelberg (KiTZ)在 kitz-heidelberg.de 的电子邮件经过验证
Bene WiestlerAI for Image-Guided Diagnosis and Therapy, TUM在 tum.de 的电子邮件经过验证
Michael BreckwoldtUniversity Clinic Heidelberg在 med.uni-heidelberg.de 的电子邮件经过验证
lawrence steinmanstanford university在 stanford.edu 的电子邮件经过验证
Sabine HeilandAbteilung Neuroradiologie在 med.uni-heidelberg.de 的电子邮件经过验证
Alba BrandesAzienda USL-Irccs Bologna在 ausl.bologna.it 的电子邮件经过验证
Mirco J. FriedrichPostdoctoral Fellow, Laboratory of Feng Zhang, Broad Institute of MIT and Harvard在 broadinstitute.org 的电子邮件经过验证
Iris OezenProjectmanager at the German Cancer Research Center在 kitz-heidelberg.de 的电子邮件经过验证
Vassilis GolfinopoulosEORTC在 eortc.org 的电子邮件经过验证

关注

Michael Platten

Professor of Neurology, German Cancer Research Center and Heidelberg University

在 dkfz.de 的电子邮件经过验证 - 首页

Neurooncology Cancer Immunology Neuroimmunology Neucosciences Neurology


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
[1, 2, 4] triazolo [1, 5-c] quinazolin-5-amines J Lefranc, N Schmees, L Zorn, RM Meier, SA Herbert, J Günther, I Gutcher, ... US Patent App. 17/634,930, 2023		2023
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists J Lefranc, N Schmees, U Röhn, L Zorn, J Günther, I Gutcher, L Röse, ... US Patent 11,304,946, 2022		2022
2-heteroaril-3-okso-2, 3-dihidropiridazin-4-karboksamidai, skirti vėžio gydymui I GUTCHER, R Ulrike, N Schmees, L Zorn, R Lars, B Bader, C KOBER, ...		2021
2-heteroaril-3-okso-2, 3-dihidropiridazin-4-karboksamidi za liječenje raka I Gutcher, R Ulrike, N Schmees, L Zorn, R Lars, B Bader, C Kober, ... HR Patent App. P20210143T T, 2021		2021
2-heteroaril-3-oxo-2, 3-dihidropiridazin-4-carboxamidas N Schmees, I Gutcher, H Irlbacher, B Bader, D Stockigt, L Rose, L Zorn, ...		2019
2-heteroaril-3-oxo-2, 3-dihidropiridazin-4-carboxamidas para el tratamiento del cancer B Bader, L Zorn, N Schmees, H Irlbacher, I Gutcher, M Platten, U Röhn, ...		2019
2-Heteroaril-3-oxo-2, 3-dihidropiridazin-4-carboxamidas para el tratamiento del cáncer I Gutcher, U Röhn, N Schmees, L Zorn, L Röse, B Bader, C Kober, ... ES Patent App. 18,703,958 T, 2021		2021
2-heteroaril-3-oxo-2, 3-dihidropiridazin-4-carboxamidas. L Zorn, B Bader, H Irlbacher, I Gutcher, U Röhn, N Schmees, L Röse, ...		2020
2-heteroaryl-3-oxo-2, 3-dihydropyridazin-4-carboxamider til behandling af cancer I Gutcher, U Röhn, N Schmees, L Zorn, L Röse, B Bader, R Carretero, ...		2021
2-heteroaryl-3-oxo-2, 3-dihydropyridazine-4-carboxamides for the treatment of cancer I Gutcher, N Schmees, L Röse, B Bader, C Kober, R Carretero, D Stöckigt, ... US Patent 11,795,164, 2023		2023
2-heteroaryl-3-oxo-2, 3-dihydropyridazine-4-carboxamides for the treatment of cancer U Rohn, N Schmees, L Zorn, R Karretero, L Rose, B Bader, C Kober, ...		2021
2-heteroaryl-3-oxo-2, 3-dihydropyridazine-4-carboxamides for the treatment of cancer I Gutcher, R Ulrike, N Schmees, L Zorn, R Lars, B Bader, C Kober, ...	1	2018
2-hétéroaryl-3-oxo-2, 3-dihydropyridazine-4-carboxamides pour le traitement du cancer N Schmees, L Röse, L Zorn, U Röhn, D Stöckigt, B Bader, H Irlbacher, ...		2021
2-phenylpyrimidine-4-carboxamides as AHR inhibitors J Lefranc, N Schmees, U Röhn, L Zorn, J Günther, I Gutcher, L Röse, ... US Patent 11,524,944, 2022	1	2022
2320P Detection of gene fusion-induced neoepitopes in dedifferentiated liposarcoma P Horak, J Becker, S Blobner, D Weber, S Uhrig, J Förster, A Raveendran, ... Annals of Oncology 34, S1185, 2023		2023
3-oxo-2, 6-diphenyl-2, 3-dihydropyridazine-4-carboxamides N Schmees, I Gutcher, H Irlbacher, B Bader, N Zhao, M Platten, U Röhn, ... US Patent 11,040,035, 2021	1	2021
3-oxo-6-heteroaryl-2-phenyl-2, 3-dihydropyridazine-4-carboxamides I Gutcher, U Röhn, L Zorn, L Röse, B Bader, C Kober, R Carretero, ... US Patent 11,591,311, 2023		2023
3, 4-DAA, an orally active synthetic tryptophan catabolite, treats established autoimmune neuroinflammation M Platten, P Ho, S Youssef, H Garren, P Fontoura, R Sobel, M Selley, ... Aktuelle Neurologie 32 (S 4), P579, 2005		2005
352 Targeting glioblastoma with a TCR specific to the HLA-A* 02-restricted, glioblastoma-associated antigen PTPRZ1 YC Chih, P Koopmann, AC Dietsch, DA Agardy, A De Roia, A Kourtesakis, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023		2023
374 Discovery of mutant IDH1 reactive T cell receptors for transgenic T cell therapy J Michel, K Sanghvi, K Lindner, A Dietsch, K Jähne, T Bunse, W Wick, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023		2023

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用